Cargando…

Association Between Intermediate-Acting Neuromuscular-Blocking Agents and Short-Term Postoperative Outcomes in Patients with Gastric Cancer

PURPOSE: This study examined whether different neuromuscular-blocking agents (NMBAs) work differently on the short-term outcomes of gastric cancer patients in terms of laboratory test results and severity of postoperative illness, and whether the effect is dose-related. PATIENTS AND METHODS: Data of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Lingxia, Yao, Chunlin, Wang, Yu, Sun, Yan, Xu, Juan, Lin, Yun, Yao, Shanglong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654551/ https://www.ncbi.nlm.nih.gov/pubmed/33192096 http://dx.doi.org/10.2147/CMAR.S258016

Ejemplares similares

Efficacy and Safety of Neuromuscular Blockade in Overweight Patients Undergoing Nasopharyngeal Surgery
por: Niu, Lingxia, et al.
Publicado: (2020)

Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study
por: Grosse-Sundrup, Martina, et al.
Publicado: (2012)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
por: Cho, Sung-Ae, et al.
Publicado: (2022)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
por: Wu, Yan, et al.
Publicado: (2022)

Neuromuscular blocking agents in the intensive care unit
por: Rodríguez-Blanco, Jonathan, et al.
Publicado: (2022)

Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Byum, et al.
Publicado: (2017)

Tracheal Intubation Without the Use of Neuromuscular Blocking Agents
por: Prakash, Smita
Publicado: (2012)

Neuromuscular blocking agents for acute respiratory distress syndrome
por: Torbic, Heather, et al.
Publicado: (2019)

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
por: Hafeez, Khawaja Rashid, et al.
Publicado: (2018)

Erratum: Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Beom, et al.
Publicado: (2017)

Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
por: Li Bassi, Gianluigi, et al.
Publicado: (2022)

Urgent intubation without neuromuscular blocking agents and the risk of tracheostomy
por: Fujinaga, Jun, et al.
Publicado: (2019)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey
por: Kim, Jin Sun, et al.
Publicado: (2019)

The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex
por: Oh, Tak Kyu, et al.
Publicado: (2019)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Potential cross-allergic reaction from pholcodine and neuromuscular blocking agents
Publicado: (2022)

Is it appropriate for acute respiratory distress syndrome patients with neuromuscular blocking agents?
por: Tan, Zhimin, et al.
Publicado: (2023)

Residual neuromuscular block in the postanesthesia care unit: incidence, risk factors, and effect of neuromuscular monitoring and reversal agents
por: ÖZBEY, Nazlı Bahar, et al.
Publicado: (2022)

Reversal of neuromuscular block
por: Bhalotra, Anju Romina
Publicado: (2018)

Factors Associated with the Underuse of Sedatives and Neuromuscular Blocking Agents for Pediatric Emergency Endotracheal Intubation in Korea
por: Lee, Jeong-Yong, et al.
Publicado: (2022)

Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2016)

Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions
por: Hagau, Natalia, et al.
Publicado: (2013)

Endotracheal Intubation Without Neuromuscular Blocking Agents: Is It a Good and Safe Option?
por: Akan, Mert, et al.
Publicado: (2012)

Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones
por: Elst, Jessy, et al.
Publicado: (2021)

Neuromuscular blocking agents/nitric oxide: Lack of efficacy: 3 case reports
Publicado: (2021)

Short-term and intermediate-term readmission after esophagectomy
por: Wang, Yoyo, et al.
Publicado: (2021)

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
por: Domenech, Gonzalo, et al.
Publicado: (2019)

The effects of sevoflurane with propofol and remifentanil on tracheal intubation conditions without neuromuscular blocking agents
por: Kim, Wook Jong, et al.
Publicado: (2010)

Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey
por: Nava-Ocampo, A A, et al.
Publicado: (2002)

Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent
por: Zhang, Xiangjun, et al.
Publicado: (2019)

Use of Sedatives and Neuromuscular-Blocking Agents in Mechanically Ventilated Patients with COVID-19 ARDS
por: Ego, Amédée, et al.
Publicado: (2021)

Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management
por: Wu, HaoTian, et al.
Publicado: (2022)

Potentially disastrous reversal of neuromuscular block agents before removing Mayfield head holder
por: Santos, Christiano dos Santos e, et al.
Publicado: (2020)

Development and validation of a PBRM1‐associated immune prognostic model for clear cell renal cell carcinoma
por: Chen, Jiayi, et al.
Publicado: (2021)

Neuromuscular monitoring and neuromuscular blocking agent shortages when treating critically ill COVID-19 patients: a multicentre retrospective analysis
por: Ziatkowski-Michaud, Julia, et al.
Publicado: (2021)

Evaluation of the Effect of Dexmedetomidine on Postoperative Cognitive Dysfunction through Aβ and Cytokines Analysis
por: Li, Zhi, et al.
Publicado: (2021)

Multiple cross-reactivity to several types of neuromuscular blocking agents in a patient with rocuronium anaphylaxis
por: Oh, Young-Jae, et al.
Publicado: (2013)

Provider variability in the intraoperative use of neuromuscular blocking agents: a retrospective multicentre cohort study
por: Althoff, Friederike C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mlcq3360dc7i2qae51auju0674